Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.

Stamp L, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

Semin Arthritis Rheum. 2018 Oct;48(2):293-301. doi: 10.1016/j.semarthrit.2018.02.009. Epub 2018 Feb 21.

PMID:
29566967
2.

Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.

Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

J Rheumatol. 2018 Mar;45(3):419-424. doi: 10.3899/jrheum.170911. Epub 2017 Dec 15.

PMID:
29247147
3.

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.

Morillon MB, Stamp L, Taylor W, Fransen J, Dalbeth N, Singh JA, Christensen R, Lassere M.

BMJ Open. 2016 Sep 20;6(9):e012026. doi: 10.1136/bmjopen-2016-012026. Review.

4.

Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).

Christensen HD, Sheta HM, Morillon MB, Hansen IM.

Am J Case Rep. 2016 Jul 15;17:494-8.

Supplemental Content

Loading ...
Support Center